Details for Patent: 11,834,521
✉ Email this page to a colleague
Which drugs does patent 11,834,521 protect, and when does it expire?
Patent 11,834,521 protects TRULANCE and is included in one NDA.
This patent has sixteen patent family members in eleven countries.
Drugs Protected by US Patent 11,834,521
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | 11,834,521 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,834,521
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014274812 | ⤷ Subscribe | |||
Australia | 2018226473 | ⤷ Subscribe | |||
Australia | 2020205349 | ⤷ Subscribe | |||
Brazil | 112015030326 | ⤷ Subscribe | |||
Canada | 2913737 | ⤷ Subscribe | |||
China | 105764916 | ⤷ Subscribe | |||
China | 113388007 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |